NuProbe
Pre-clinicalNuProbe develops ultrasensitive and highly-multiplexed assays for low-frequency variant detection on NGS and PCR platforms
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $75M
About
NuProbe develops ultrasensitive and highly-multiplexed assays for low-frequency variant detection on NGS and PCR platforms
Diagnostics
Funding History
2Total raised:$75M
Series B$65MJan 15, 2022
Series A$10MMay 15, 2020